mutares increases its profitability significantly in H1-2015

The mutares Group (ISIN: DE000A0SMSH2) closed H1-2015 with a considerable organic growth in revenues and a significant increase in profitability based on preliminary figures. Given the dynamic transaction activities in 2015, mutares is confident to achieve another record year.

Despite the deconsolidation of two portfolio companies (CGVL and Suir Pharma) the mutares Group increased its revenues in H1-2015 to the record level of EUR 311.6m (H1-2014: EUR 307.5m) based on preliminary consolidated figures. Primary drivers were EUPEC, STS Acoustics, Elastomer Solutions, and Geesinknorba. The four companies achieved an organic growth in revenues of more than 25% compared to H1-2014. The operating earnings (EBITDA) of the Group could be increased significantly by 24.7% to EUR 12.9m (H1-2014: EUR 10.4m). In particular, the positive development at EUPEC, STS Acoustics, and Elastomer Solutions contributed to this result.

After the acquisitions of the specialty paper manufacturer Zanders and the pipeline manufacturer BSL, mutares successfully closed the acquisition of the French omni-channel distributor Grosbill (www.grosbill.com) from Groupe Auchan. In 2014, Grosbill generated sales of EUR 109m with 150 employees via its website and its network of nine stores. Based on its dynamic transaction activities and a well filled M&A pipeline, mutares expects a further revenue increase in H2-2015. Hence, the seventh consecutive record year can be expected. The half year report of the mutares Group will be published on September 17, 2015.